Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021 7 1
Quercetin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 12 0
Montelukast Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/23/2021 5 0
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/09/2021 4 0
Myricetin Potential treatment - pre-clinical evidence Natural product Antiviral Jan/04/2021 5 0
Entrectinib Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/21/2020 2 0
Radotinib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Tivantinib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Lifirafenib Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Excel (.xslx) CSV (.csv)